360 filings
Page 3 of 18
8-K
i1gc48bsvbv ndzjay8x
5 Nov 20
Dynavax Announces Third Quarter 2020 Financial Results
4:08pm
8-K
bwazsrxw00brek
24 Sep 20
Departure of Directors or Certain Officers
4:11pm
8-K
sfz rnssch0x3s7b
14 Sep 20
Other Events
9:13am
8-K
xz28boi
6 Aug 20
Dynavax Announces Second Quarter 2020 Financial Results
4:06pm
8-K
bpuy8
21 Jul 20
Departure of Directors or Certain Officers
4:43pm
8-K
2j9iz
19 Jun 20
Preclinical results demonstrated the ability of CpG 1018-adjuvanted SCB-2019 to elicit neutralizing antibodies in multiple animal species
4:05pm
8-K
32n4p euh
29 May 20
Departure of Directors or Certain Officers
4:10pm
8-K
kf87njaach8l bq2tlfn
22 May 20
Other Events
4:52pm
8-K
grvaywym 2f2
21 May 20
Other Events
4:07pm
8-K
ly1fyhv 3c9pn
18 May 20
Other Events
5:02pm
8-K
kovc6xnzkqu9x5fx5
11 May 20
Departure of Directors or Certain Officers
4:10pm
8-K
15jpr1 0b
7 May 20
Dynavax Announces First Quarter 2020 Financial Results
4:17pm
8-K
kbd7426k5c
3 Apr 20
Dynavax Provides Business Update on COVID-19 Pandemic Impact
4:11pm
8-K
439x261gqv mge5
11 Mar 20
Dynavax Announces Fourth Quarter and Full Year 2019 Financial Results
4:15pm
8-K
71up1r7s
14 Feb 20
Departure of Directors or Certain Officers
12:00am
8-K
8ajr0wh j2p3x
4 Feb 20
Departure of Directors or Certain Officers
4:10pm
8-K
yota6fgnv99i7ih4 5u
16 Dec 19
Departure of Directors or Certain Officers
4:45pm
8-K
44u8x1f8457qwiqoj
3 Dec 19
Other Events
7:31am
8-K
hz7ku 8gg4
18 Nov 19
Departure of Directors or Certain Officers
4:06pm
8-K
zc6b3x e4k6w
6 Nov 19
Dynavax Announces Third Quarter 2019 Financial Results
4:15pm